Summary of Purpose
The primary objective of this trial is to demonstrate the non-inferiority of clopidogrel compared to prasugrel over 6 months in cardiovascular disease patients when the clopidogrel cohort is limited to the estimated 70% of the population that are CYP2C19 extensive metabolizers. This protocol will examine the comparative... Trial Stopped: Administrative reasonsRead More →
The following dates are available for this trial. Trial information last updated on 29 May 2012.
|1 Oct 2009||14 Oct 2009||1 May 2012||1 May 2012||1 May 2012||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- Observation: Cohort
- Perspective: Prospective
- Sampling: Non-Probability Sample